Value of cytotoxic infusion in dyspnoea and dysphagia due to cancer.
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D003520:Cyclophosphamide / Q000008:administration & dosage; D003680:Deglutition Disorders / Q000209:etiology; D004417:Dyspnea / Q000209:etiology; D004938:Esophageal Neoplasms / Q000150:complications / Q000188:drug therapy; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007263:Infusions, Parenteral; D007822:Laryngeal Neoplasms / Q000150:complications / Q000188:drug therapy; D008727:Methotrexate / Q000008:administration & dosage; D009369:Neoplasms / Q000150:complications; D010610:Pharyngeal Neoplasms / Q000150:complications / Q000188:drug therapy
D000970:Antineoplastic Agents; D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate